Vitiligo: New and emerging treatments

Dermatologic Therapy

Volumn 21, Issue 2, 2008, Pages 110-117

  Lotti, Torello ^a   Gori, Alessia ^a   Zanieri, Fabio ^a   Colucci, Roberta ^a   Moretti, Silvia ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Department of Dermatological Sciences ^*  (Italy)

Author keywords

Phototherapy; Therapy treatment; UVB; Vitiligo

Indexed keywords

ANTIOXIDANT; CALCIPOTRIOL; CORTICOSTEROID DERIVATIVE; CUCUMIS MELO EXTACT; DERMATOLOGICAL AGENT; FUROCHROMONE DERIVATIVE; FUROCOUMARIN; HYDROQUINONE; KHELLIN; MELAGENINA 1; MELAGENINA 2; MEQUINOL; MINOXIDIL; PHENYLALANINE; PIMECROLIMUS; PLANT EXTRACT; PROSTAGLANDIN E2; PSORALEN; TACROLIMUS; UNCLASSIFIED DRUG;

ACNE; AUTOTRANSPLANTATION; BLISTER; BURN; CANTALOUPE; CONTACT DERMATITIS; CRYOTHERAPY; DEPIGMENTATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; EDEMA; ERYTHEMA; EXCIMER LASER; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPERTRICHOSIS; LEUKODERMA; LOW LEVEL LASER THERAPY; MELANOSIS; MONOTHERAPY; PHOTOAGING; PHOTOTHERAPY; PREMATURE AGING; PRURITUS; PUVA; REVIEW; ROSACEA; SKIN ATROPHY; SKIN CANCER; SKIN GRAFT; SKIN INFECTION; SKIN IRRITATION; SUNBURN; TELANGIECTASIA; TISSUE ENGINEERING; TREATMENT FAILURE; ULTRAVIOLET B RADIATION; VITILIGO; XEROSIS;

ADMINISTRATION, TOPICAL; ANTIOXIDANTS; DERMATOLOGIC AGENTS; DERMATOLOGY; HUMANS; PATIENT SELECTION; SKIN PIGMENTATION; SKIN TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; ULTRAVIOLET THERAPY; VITILIGO;

EID: 41849104656     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2008.00178.x     Document Type: Review

References (59)

1. Moretti S, Amato L, Bellandi S, Fabbri P. Focus on vitiligo: a generalized skin disorder. Eur J Inflamm 2006 : 4 : 21 30.
2. Ogg GS, Dunbat PR, Romero P, Chen JL, Cerundulo V. High frequency of skin homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J Exp Med 1998 : 188 : 1203 1208.
3. Koga M, Tango T. Clinical features and course of type A and type B vitiligo. Br J Dermatol 1988 : 118 : 223 228.
4. Nordlund JJ, Lerner AB. Vitiligo. It is important. Arch Dermatol 1982 : 118 : 5 8.
5. Castanet J, Ortonne JP. Pathophysiology of vitiligo. Clin Dermatol 1997 : 15 : 845 851.
6. Van der Wijngaard RM, Aten J, Sheepmaker A, et al. Expression and modulation of apoptosis regulatory molecules in human melanocytes: significance in vitiligo. Br J Dermatol 2000 : 143 : 573 581.
7. Le Poole IC, Wankowicz-Kalinska A, Van der Wijngard RM, Nickoloff BJ, Das PK. Autoimmune aspects of depigmentation in vitiligo. J Invest Dermatol Symp Proc 2004 : 9 : 68.
8. Gauthier Y, Cario-Andre M, Lepreux M, Pain C, Taieb A. Melanocytes detachment after skin friction in non lesional skin of patients with generalized vitiligo. Br J Dermatol 2003 : 148 : 95 101.
9. Gauthier Y, Cario-Andre M, Taieb A. A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocitorragy? Pigment Cell Res 2003 : 16 : 322 332.
10. Birbeck MS, Breathnach AS, Everall JD. An electron microscope study of basal melanocyes and high level-clear cells (Langerhans cells) in vitiligo. J Invest Dermatol 1961 : 37 : 51 54.
11. Le Poole IC, Das PK, Van der Wijngard RM, Westerhof W, Dutrieux RP, Das PK. Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J Invest Dermatol 1993 : 100 : 816 822.
12. Dippel E, Haas N, Grabbe J, Schadendorf D, Hamann K, Czarnetzki BM. Expression of the c-kit receptor in hypomelanosis: a comparative study between piebaldism, naevus depigmentosus and vitiligo. Br J Dermatol 1995 : 132 : 182 189.
13. Morohashi M, Hashimoto K, Goodman TF Jr., Newton DE, Rist T. Ultrastructural studies of vitiligo, Vogt Koyanagi syndrome and incontinentia pigmentis achromians. Arch Dermatol 1997 : 13 : 755 766.
14. Medrano EE, Nordlund JJ. Successful culture of adult human melanocytes obtained from normal and vitiligo donors. J Invest Dermatol 1990 : 95 : 441 445.
15. Tobin DJ, Swanson NN, Pittelkow MR, Peters EM, Schallreuter KU. Melanocytes are not absent in lesional skin of long duration vitiligo. J Pathol 2000 : 191 : 407 416.
16. Menchini G, Lotti T, Tsoureli-Nikita E, Hercogova J. UV-B Narrowband microphototherapy: a new treatment for vitiligo. In : Lotti T, Hercogová J, eds. Vitiligo, problems and solutions, 1st ed. New York-Basel : Marcel Dekker, Inc., 2004 : 323 334.
17. Hercogová J, Buggiani G, Prignano F, Lotti T. A rational approach to the treatment of vitiligo and other hypomelanoses. In : Lotti T, Thiers BH, eds. Pigmentary disorders. Ed Elsevier Saunders. Dermatol Clin 2007 : 25 : 383 392.
18. Fitzpatrick TB, Allen Johnson R, Wolff K, Suurmond D. Vitiligo. In : Color atlas and synopsis of clinical dermatology. Common and serious disease. New York : Mcgraw-Hill Companies, 1997.
19. Westerhof W, D'Ischia M. Vitiligo puzzle: the pieces fall in place. Pigment Cell Res 2007 : 20 : 345 359.
20. Posonsby AL, Lucas RM, Van Der Mei IA. UVR, vitamin D and three autoimmune diseases-multiple sclerosis, type-1 diabetes, rheumatoid arthritis. Photochem Photobiol 2005 : 81 : 1267 1275.
21. El Ghorr AA, Norval M. Biological effects of narrow band (301 nn TL01) UVB irradiation: a review. J Photochem Photobiol B 1997 : 38 : 99 106.
22. Hirobe T. The role of keratinocyes derived factors involved in the proliferation and differentiation of mammalian epidermal melanocytes. Pigment Cell Res 2005 : 18 : 2 12.
23. Moretti S, Spallanzani A, Amato L, et al. New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res 2002 : 15 : 87 92.
24. Osawa M, Egawa G, Mak SS, et al. Molecular characterization of melanocyte stem cells in their niche. Development 2005 : 132 : 5589 5599.
25. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation vs. topical psoralen plus UV-A. Arch Dermatol 1997 : 133 : 1525 1528.
26. Lecha M. Use of UVB in vitiligo. In : Lotti T, Hercogová J, eds. Vitiligo, problems and solutions, 1st ed. New York-Basel : Marcel Dekker, Inc, 2004 : 341 347.
27. Lotti T, Prignano F, Buggiani G. New and experimental treatment of vitiligo and other hypomelanoses. In : Lotti T, Thiers BH, eds. Pigmentary disorders. Ed Elsevies Saunders. Dermatol Clin 2007 : 25 : 393 400.
28. Lotti T, Menchini G, Andreassi L. UV-B radiation microphototherapy: an elective treatment for segmental vitiligo. J Eur Acad Dermatol Venereol 1999 : 13 : 102 108.
29. Menchini G, Tsoureli-Nikita E, Hercogová J. Narrowband UV-B radiation microphototherapy: a new treatment for vitiligo. J Eur Acad Dermatol Venereol 2003 : 17 : 171 177.
30. Lotti T, Rossi R, Campolmi P. Targeted UVB therapy: when and why to start. Arch Dermatol 2006 : 142 : 933 934.
31. Esposito M, Soda R, Costanzo A, Chimenti S. Treatment of vitiligo with the 308-nm excimer laser. Clin Exp Dermatol 2004 : 29 : 133 137.
32. Leone G, Iacovelli P, Paro Vidolin A, Picardo M. Monochromatic excimer light in the treatment of vitiligo: a pilot study. J Eur Acad Dermatol Venereol 2003 : 17 : 531 537.
33. Grimes PE, Soriano T, Dytoc M. Topical tacrolimus for repigmentation of vitiligo. J Am Acad Dermatol 2002 : 47 : 789 791.
34. Grimes PE, Morris R, Avaniss-Aghajani E, Soriano T, Meraz M, Metzger A. Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines. J Am Acad Dermatol 2004 : 51 : 52 61.
35. Passeron T, Ostovari N, Zakaria W, et al. Topical tacrolimus and the 308 nm excimer laser: a synergistic combiantion for treatment of vitiligo. Arch Dermatol 2004 : 140 : 1065 1069.
36. Parsad D, Pandhi R, Dogra S, Kumar B. Topical prostaglandin analog (PGE2) in vitiligo: preliminary study. Int J Dermatol 2002 : 41 : 942 945.
37. Schallreuter KU, Pittelkow MR, Swanson NN. Defective calcium transport in vitiliginous melanocytes. Arch Dermatol Res 1996 : 288 : 11 13.
38. Milde P, Huser U, Simon T, et al. Expression of 1,25 dihydroxivitamin D3 receptors in normal and psoriatic skin. J Invest Dermatol 1991 : 97 : 230 239.
39. Chiaverini C, Passeron T, Ortonne JP. Treatment of vitiligo by topical calcipotriol. J Eur Acad Dermatol 2002 : 16 : 137 138.
40. Ermis O, Alpsov E, Cetin L, Yilmaz E. Is the efficacy of psoralen plus ultarviolet a therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo controlled double blind study. Br J Dermatol 2001 : 145 : 472 475.
41. Parsad D, Phandi R, Dogra S, Kumar B. Clinical study of repigmenattion patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches. J Am Acad Dermatol 2004 : 50 : 63 67.
42. Baysal W, Yildirim M, Erel A, Kesici D. Is the combination of calcipotriol and PUVA effective in vitiligo? J Acad Dermatol Venereol 2003 : 17 : 299 302.
43. 2 stress. J Invest Dermatol 2004 : 122 : 307 313.
44. Koca R, Armutcu F, Altinyazar HC, Gürel A. Oxidant-antioxidant enzymes and lipid peroxidation in generalized vitiligo. Clin Exp Dermatol 2004 : 29 : 406 409.
45. Schallreuter KU, Moore J, Behrens-Williams S, Panske A, Harari M. Rapid initation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC-KUS). Int J Dermatol 2002 : 41 : 482 487.
46. Schallreuter KU, Wood JM, Lemke KR, Levenig C. Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients. Dermatology 1995 : 190 : 223 229.
47. Khemis A, Ortonne JP. Etude comparative d'un extrait vegetal possedant une activité superoxide dismutase (VITIX®) plus phototherapie UVB selective versus son excipient plus phototherapie selective dans le traitement du vitiligo vulgaire. Nouvelle Dermatologique 2004 : 23 : 7 11.
48. Dell'Anna ML, Mastrofrancesco A, Sala R, et al. Antioxidants and narrow band UVB in the treatmant of vitiligo: a double blind placebo controlled trial. Clin Exp Dermatol 2007 : 32 : 631 636.
49. Middelkamp-Hup MA, Bos JD, Rius-Diaz F, Gonzales S, Westerhof W. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized trial double-bind placebo-controlled study. J Eur Acad Dermatol 2007 : 21 : 942 950.
50. Chen YF, Yang PY, Hu DN, Kuo FS, Hung CS, Hung CM. Treatment of vitiligo by transplantation of cultured pure melanocytes suspension: analysis of 120 cases. J Am Acad Dermatol 2004 : 51 : 68 74.
51. Gupta S, Kumar B. Epidermal grafting in vitiligo: influence of age, site of lesion and type of disease on outcome. J Am Acad Dermatol 2003 : 49 : 99 104.
52. Andreassi A, Pianigiani E, Taddeucci P, et al. Tissue-engineered skin in the treatment of vitiligo lesions. In : Lotti T, Hercogovà J, eds. Vitiligo: problems and solutions. New York : Marcel Dekker, Inc., 2004 : 313 321.
53. Leachman S. Surgical therapies. Part III. Melanocyte transplants. Dermatol Ther 2001 : 14 : 20 28.
54. Andreassi L, Pianigiani E, Andreassi A, Taddeucci P, Biagioli M. A new model of epidermal culture for the surgical treatment of vitiligo. Int J Dermatol 1998 : 37 : 595 598.
55. Antoniou C, Nicolaidou E. Depigmentation and vitiligo. In : Lotti T, Hercogovà J, eds. Vitiligo: problems and solutions. New York : Marcel Dekker, Inc., 2004 : 359 364.
56. Njoo MD, Vodegel RM, Westerhof W. Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and Q-switched ruby laser. J Am Acad Dermatol 2000 : 42 : 760 769.
57. Radmanesh M. Depigmentation of the normally pigmented patches in universal vitiligo patients by cryotherapy. J Eur Acad Dermatol 2000 : 14 : 149 152.
58. Kim YJ, Chung BS, Choi KC. Depigmentation therapy with Q-switched ruby laser after tanning in vitiligo universalis. Dermatol Surg 2001 : 27 : 969 970.
59. Ghersetich I, Brazzini B, Lotti T, et al. Alternative treatments for vitiligo. In : Lotti T, Hercogovà J, eds. Vitiligo: problems and solutions. New York : Marcel Dekker, Inc., 2004 : 285.